## **Core Concept**
Neovascular glaucoma (NVG) is a severe form of glaucoma characterized by the formation of new, fragile vessels on the iris and over the trabecular meshwork, leading to increased intraocular pressure (IOP). It often results from ischemic retinal diseases that stimulate the production of vascular endothelial growth factors (VEGF), promoting neovascularization. The most common causes are related to retinal ischemia.

## **Why the Correct Answer is Right**
The correct answer, **Diabetic Retinopathy**, is a leading cause of neovascular glaucoma due to its potential to cause retinal ischemia. In diabetic retinopathy, especially proliferative diabetic retinopathy, retinal ischemia can lead to the release of VEGF. This growth factor promotes the growth of new vessels, which can lead to neovascularization of the iris and the trabecular meshwork, obstructing aqueous outflow and resulting in increased IOP.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **Central Retinal Vein Occlusion (CRVO)** can cause neovascular glaucoma, especially if it results in retinal ischemia, it is not as common a cause as diabetic retinopathy. CRVO leads to retinal ischemia, which can stimulate neovascularization.
- **Option B:** **Ocular Trauma** can cause a variety of complications, including neovascular glaucoma, but it is not the most common cause. Trauma can lead to ischemia or inflammation that might result in neovascularization.
- **Option C:** **Rhegmatogenous Retinal Detachment** is not typically associated with neovascular glaucoma directly. This condition involves a tear in the retina leading to detachment, and while it can cause severe vision problems, it is not commonly linked to NVG.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that neovascular glaucoma often presents with severe vision loss and high IOP. Early recognition and treatment of the underlying cause, such as diabetic retinopathy or central retinal vein occlusion, are crucial. **Panretinal photocoagulation (PRP)** is a treatment used to reduce ischemia and subsequent VEGF production, thereby reducing the risk of NVG.

## **Correct Answer:** . Diabetic Retinopathy